Stemmler HJ - Search Results

1

Prospective multicenter randomized phase III study of weekly versus standard docetaxel plus doxorubicin (D4) for first-line treatment of metastatic breast cancer.

Stemmler HJ, Harbeck N, Gröll de Rivera I, Vehling Kaiser U, Rauthe G, Abenhardt W, Artmann A, Sommer H, Meerpohl HG, Kiechle M, Heinemann V. Stemmler HJ, et al. Oncology. 2010;79(3-4):204-10. doi: 10.1159/000320625. Epub 2011 Mar 1. Oncology. 2010. PMID: 21358208 Clinical Trial.

2

Weekly docetaxel (Taxotere) in patients with metastatic breast cancer.

Stemmler HJ, Gutschow K, Sommer H, Malekmohammadi M, Kentenich CH, Forstpointner R, Geuenich S, Bischoff J, Hiddemann W, Heinemann V. Stemmler HJ, et al. Ann Oncol. 2001 Oct;12(10):1393-8. doi: 10.1023/a:1012557528952. Ann Oncol. 2001. PMID: 11762809 Free article. Clinical Trial.

3

Gastrointestinal toxicity associated with weekly docetaxel treatment.

Stemmler HJ, Kenngotte S, Diepolder H, Heinemann V. Stemmler HJ, et al. Ann Oncol. 2002 Jun;13(6):978-81. doi: 10.1093/annonc/mdf084. Ann Oncol. 2002. PMID: 12123345 Free article.

4

Re-evaluation of HER2 status in metastatic breast cancer and tumor-marker guided therapy with vinorelbine and trastuzumab.

Stemmler HJ, Stieber P, Lässig D, Heinemann V. Stemmler HJ, et al. Onkologie. 2005 Feb;28(2):95-7. doi: 10.1159/000082803. Epub 2005 Feb 3. Onkologie. 2005. PMID: 15692222 Free article.

5

Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer.

Stemmler HJ, Kahlert S, Siekiera W, Untch M, Heinrich B, Heinemann V. Stemmler HJ, et al. Breast. 2006 Apr;15(2):219-25. doi: 10.1016/j.breast.2005.04.017. Epub 2005 Jul 18. Breast. 2006. PMID: 16026983

6

Brain metastases in metastatic non-small cell lung cancer responding to single-agent gefitinib: a case report.

Stemmler HJ, Weigert O, Krych M, Schoenberg SO, Ostermann H, Hiddemann W. Stemmler HJ, et al. Anticancer Drugs. 2005 Aug;16(7):747-9. doi: 10.1097/01.cad.0000171770.82058.1c. Anticancer Drugs. 2005. PMID: 16027524

7

Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: a pilot study.

Stemmler HJ, Salat C, Lindhofer H, Menzel H, Untch M, Kahlert S, Konecny G, Sauer H, Ledderose G, Heinemann V, Kolb HJ. Stemmler HJ, et al. Anticancer Res. 2005 Jul-Aug;25(4):3047-54. Anticancer Res. 2005. PMID: 16080564 Free article. Clinical Trial.

8

High efficacy of gemcitabine and cisplatin in patients with predominantly anthracycline- and taxane-pretreated metastatic breast cancer.

Heinemann V, Stemmler HJ, Wohlrab A, Bosse D, Losem C, Kahlert S, Rauthe G. Heinemann V, et al. Among authors: stemmler hj. Cancer Chemother Pharmacol. 2006 May;57(5):640-6. doi: 10.1007/s00280-005-0093-5. Epub 2005 Sep 15. Cancer Chemother Pharmacol. 2006. PMID: 16163537 Clinical Trial.

9

Lasting remission following multimodal treatment in a patient with metastatic breast cancer.

Stemmler HJ, Menzel H, Salat C, Lindhofer H, Kahlert S, Heinemann V, Kolb HJ. Stemmler HJ, et al. Anticancer Drugs. 2005 Nov;16(10):1135-7. doi: 10.1097/01.cad.0000180122.24031.13. Anticancer Drugs. 2005. PMID: 16222157

10

Prolonged survival of patients receiving trastuzumab beyond disease progression for HER2 overexpressing metastatic breast cancer (MBC).

Stemmler HJ, Kahlert S, Siekiera W, Untch M, Heinrich B, Heinemann V. Stemmler HJ, et al. Onkologie. 2005 Nov;28(11):582-6. doi: 10.1159/000088296. Onkologie. 2005. PMID: 16249644

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters